Could a simple drug cut bleeding risk in weight-loss surgery?
NCT ID NCT07754396
First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time
Summary
This study looks at whether giving tranexamic acid during weight-loss (bariatric) surgery can reduce bleeding. Researchers will compare patients who received the drug with those who did not, focusing on drops in hemoglobin levels, need for transfusions, hospital stay length, and blood clot complications. The study includes adults who had bariatric surgery at a single hospital.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tranexamic acid
- What this could lead to
- If effective, tranexamic acid could become a standard preventive measure to reduce bleeding complications and transfusions in bariatric surgery.
- What could go wrong
- This is a retrospective observational study, so it cannot prove cause and effect. There is also a potential risk of blood clots, which the study will monitor.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MORBID OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
General Hospital of Athens G. Gennimatas
Athens, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?